Who Receives Optimal Medical Care?

1973 ◽  
Vol 14 (2) ◽  
pp. 176 ◽  
Author(s):  
Michael H. Miller
2005 ◽  
Vol 33 (3) ◽  
pp. 566-574 ◽  
Author(s):  
Paul Litton ◽  
Franklin G. Miller

In the research ethics literature, there is strong disagreement about the ethical acceptability of placebo-controlled trials, particularly when a tested therapy aims to alleviate a condition for which standard treatment exists. Recently, this disagreement has given rise to debate over the moral appropriateness of the principle of clinical equipoise for medical research. Underlying these debates are two fundamentally different visions of the moral obligations that investigators owe their subjects.Some commentators and ethics documents claim that physicians, whether acting as care givers or researchers, have the same duty of beneficence towards their patients and subjects: namely, that they must provide optimal medical care. In discussing placebo surgery in research on refractory Parkinson's disease, Peter Clark succinctly states this view: “The researcher has an ethical responsibility to act in the best interest of subjects.”


Circulation ◽  
1986 ◽  
Vol 74 (5) ◽  
pp. 917-919 ◽  
Author(s):  
P S Douglas

2020 ◽  
Vol 4 (3) ◽  
pp. 79-88 ◽  
Author(s):  
EWA BAUM ◽  
AGNIESZKA ŻOK

Maximal individualism, which is currently a prevalent trend in the way many patients think, places high hopes in the achievements of biomedicine and assumes that everyone should always receive optimal medical care. Such an approach is in line with many normative and legal acts operating worldwide, including the Declaration of Human Rights. However, its feasibility and effectiveness in the time of the COVID-19 pandemic raises numerous ethical, social and economic dilemmas. The culture of prosperity and excess, characteristic of contemporary Western societies, makes it even more challenging to come to terms with this situation.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Marcio L. Griebeler ◽  
Kevin M. Pantalone ◽  
Ron Gambino ◽  
David Shewmon ◽  
Jay Morrow ◽  
...  

AbstractThe COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an efficient, effective, and safe manner. Endocrinology diseases are commonly present in patients with COVID-19 and often are major risk factors for development of severe disease. The use of electronic consultation and telemedicine have already been well-established in the outpatient setting but yet not commonly implemented in the inpatient arena. This type of remote medical care has the potential to provide a reliable delivery of endocrine care while protecting providers and patients from spreading infection. This short review intends to provide the initial steps for the development of an inpatient telemedicine endocrine service to patients with endocrine diseases. Telehealth will become part of our daily practices and has a potential to provide a safe and efficient method of consultative service.


2014 ◽  
Vol 67 (10) ◽  
pp. 1150-1156 ◽  
Author(s):  
Jean Raymond ◽  
Tim E. Darsaut ◽  
Douglas G. Altman

2021 ◽  
pp. bjsports-2021-104235
Author(s):  
Stanley Herring ◽  
W Ben Kibler ◽  
Margot Putukian ◽  
Gary S Solomon ◽  
Lori Boyajian-O'Neill ◽  
...  

Selected Issues in Sport-Related Concussion (SRC|Mild Traumatic Brain Injury) for the Team Physician: A Consensus Statement is title 22 in a series of annual consensus documents written for the practicing team physician. This document provides an overview of selected medical issues important to team physicians who are responsible for athletes with sports-related concussion (SRC). This statement was developed by the Team Physician Consensus Conference (TPCC), an annual project-based alliance of six major professional associations. The goal of this TPCC statement is to assist the team physician in providing optimal medical care for the athlete with SRC.


Sign in / Sign up

Export Citation Format

Share Document